Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definition
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing demand for biopharmaceutical products
3.2.1.2 Advancements in biotechnology and bioprocessing
3.2.1.3 Increasing demand for biosimilars
3.2.1.4 Rising government initiatives and funding
3.2.2 Industry pitfalls & challenges
3.2.2.1 High cost of instruments
3.2.2.2 Complexity and technical expertise
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technology landscape
3.6 Reimbursement scenario
3.7 Pricing analysis at manufacture level, 2023
3.8 Future market trends
3.9 Porter’s analysis
3.10 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Instruments
5.3 Consumables and accessories
Chapter 6 Market Estimates and Forecast, By Analysis Type, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Substrate analysis
6.3 Metabolite analysis
6.4 Concentration detection
Chapter 7 Market Estimates and Forecast, By Application, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Antibiotics
7.3 Recombinant proteins
7.4 Biosimilars
7.5 Other applications
Chapter 8 Market Estimates and Forecast, By End Use, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Biopharmaceutical companies
8.3 CROs & CMOs
8.4 Research and academic institutes
8.5 Other end users
Chapter 9 Market Estimates and Forecast, By Sales Channel, 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Direct sales
9.3 Distributors and wholesalers
9.4 Specialty retailers
9.5 Value-added resellers (VARs)
Chapter 10 Company Profiles
10.1 Agilent Technologies
10.2 4BioCell
10.3 Danaher Corporation
10.4 Eppendorf
10.5 F. Hoffmann-La Roche
10.6 Nova Biomedical
10.7 Thermo Fisher Scientific
10.8 Sartorius
10.9 Solida Biotech
10.10 YSI
